VN
Vishav Nath Jindal
About Vishav Nath Jindal
Data last updated:
Vishav Nath Jindal is a Director at Astrofine Pharma Private Limited (since 2021), Director at Shinzo Pharma Private Limited (since 2022) and Director at Abinza Pharma Private Limited (since 2021), and holds 3 more current directorships. The companies operate in Pharma and Paper. The 3 current companies with reported revenue have a combined latest revenue of ₹2.17 Cr; the largest is Astrofine Pharma Private Limited at ₹1.70 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Astrofine Pharma Private Limited U24290HP2021PTC008952 | Director | 10 Nov 2021 | 2021 | ₹1.70 Cr (FY 2024) | Active |
| Shinzo Pharma Private Limited U24246HP2022PTC009394 | Director | 22 Jun 2022 | 2022 | ₹46.4 Lakh (FY 2024) | Active |
| Abinza Pharma Private Limited U24233JK2021PTC012734 | Director | 20 Sep 2021 | 2021 | ₹58,215 (FY 2024) | Active |
| Aanvis Pharma Private Limited U21000PB2024PTC061842 | Director | 14 Jun 2024 | 2024 | Active | |
| Scorda Pharma Private Limited U21004HP2024PTC010851 | Director | 28 Apr 2024 | 2024 | Active | |
| Ivcure Pharma Private Limited U21002HP2024PTC010825 | Director | 22 Apr 2024 | 2024 | Active |
Board colleagues of Vishav Nath Jindal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pushpendra Singh | 07454065 | Astrofine Pharma Private Limited | Director |
| Renu Sharma | 09647498 | Shinzo Pharma Private Limited | Director |
| Sanjeev Goel | 03478815 | Abinza Pharma Private Limited , Scorda Pharma Private Limited and 1 more | Director |
| Sachin Kumar Sharma | 10973388 | Aanvis Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishav Nath Jindal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishav Nath Jindal
Vishav Nath Jindal currently holds 6 directorships: Astrofine Pharma Private Limited (Director, since 10 Nov 2021, revenue ₹1.70 Cr (FY 2024)); Shinzo Pharma Private Limited (Director, since 22 Jun 2022, revenue ₹46.4 Lakh (FY 2024)); Abinza Pharma Private Limited (Director, since 20 Sep 2021, revenue ₹58,215 (FY 2024)); Aanvis Pharma Private Limited (Director, since 14 Jun 2024); Scorda Pharma Private Limited (Director, since 28 Apr 2024); and 1 more.
Vishav Nath Jindal was first appointed on 20 Sep 2021 as Director at Abinza Pharma Private Limited. The most recent appointment on record is 14 Jun 2024 at Aanvis Pharma Private Limited.
The 3 current companies of Vishav Nath Jindal that report revenue have a combined latest revenue of ₹2.17 Cr: Astrofine Pharma Private Limited ₹1.70 Cr (FY 2024); Shinzo Pharma Private Limited ₹46.4 Lakh (FY 2024); Abinza Pharma Private Limited ₹58,215 (FY 2024).
The current boards of Vishav Nath Jindal's companies include Pushpendra Singh (Astrofine Pharma Private Limited), Renu Sharma (Shinzo Pharma Private Limited), Sanjeev Goel (Abinza Pharma Private Limited), Sachin Kumar Sharma (Aanvis Pharma Private Limited).